What is ByHeart?
Founded in 2016 and headquartered in New York City, ByHeart operates as a fully integrated baby nutrition enterprise. By maintaining its own manufacturing facilities in Pennsylvania, the company exerts direct control over its supply chain and product quality. Beyond its core nutritional offerings, ByHeart has expanded its digital footprint with the launch of Cluster, a platform designed to provide parents with educational resources and support throughout the pregnancy and toddler stages. This dual-pronged approach of physical product innovation and digital community engagement positions ByHeart as a comprehensive partner for modern families navigating the complexities of early childhood nutrition.
How much funding has ByHeart raised?
ByHeart has raised a total of $328.8M across 5 funding rounds:
Series A
$70M
Series B
$90M
Grant
$1.8M
Other Financing Round
$95M
Other Financing Round
$72M
Series A (2020): $70M with participation from OCV Partners, Sean Parker, Red Sea Ventures, Polaris Partners, D1 Capital Partners, Two River, and Bellco Capital
Series B (2021): $90M led by OCV Partners, D1 Capital Partners, Two River, Bellco Capital, and Polaris Partners
Grant (2021): $1.8M, investors not publicly disclosed
Other Financing Round (2024): $95M featuring Gaingels, Red Sea Ventures, and AF Ventures
Other Financing Round (2025): $72M, investors not publicly disclosed
Key Investors in ByHeart
OCV Partners
OCV Partners is a venture capital firm based in Los Angeles that specializes in investing in companies with differentiated technologies in high-potential markets, particularly in sectors such as SaaS, FinTech, PropTech, and healthcare.
Red Sea Ventures
Red Sea Ventures is a New York City-based venture capital fund that invests in early-stage technology-enabled companies aimed at transforming industries and enhancing consumer experiences.
Polaris Partners
Polaris Partners is a venture capital firm that specializes in backing transformational companies in the biotech and healthcare sectors, providing coaching and resources for growth.
What's next for ByHeart?
The infusion of capital from the latest strategic investment round is expected to accelerate ByHeart's operational scaling and market penetration. As the company transitions from its earlier growth phases into a more mature enterprise-level lifecycle, the focus will likely shift toward optimizing its manufacturing throughput and expanding the reach of its digital ecosystem. By leveraging its existing infrastructure and the support of its diverse investor base, ByHeart is well-positioned to challenge legacy incumbents in the baby nutrition market, potentially exploring new product categories or international expansion to sustain its upward trajectory.
See full ByHeart company page
